Drawing for HARNESSING THE POWER OF SCIENCE AND NATURE

USPTO serial 85349346

HARNESSING THE POWER OF SCIENCE AND NATURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KIM, SOPHIA SUJIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HARNESSING THE POWER OF SCIENCE AND NATURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer L. Whitelaw

JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N STE 310NAPLES, FL 34103-3586UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; herbal extracts and extract blends for medical purposes; botanical extracts and extract blends for medical purposes; nutritional supplements; herbal products, namely, medicated skin and lip balms; herbal products, namely, ointments, oils, drinks, infusions, syrups, herbal extracts, poisons, tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products, namely, mentholated ointments for medical use; oils, namely, medicated mineral oil for use as a laxative; drinks, namely, meal replacement drinks; dietary supplement drinks, medicinal drinks, and fish oil for use as a dietary supplement and as a nutraceutical dietary supplement; syrups, namely, cough syrups; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, herbal extracts and syrups; medicinal herb extracts; medicinal herb extracts for medical purposes; plant extracts for medical or pharmaceutical purposes; plant extracts for medical and nutritional purposes; plant extracts for medical and pharmaceutical purposes; medicinal herbal extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanical extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; yeast extracts for medical or pharmaceutical purposes; yeast extracts for medical or nutraceutical purposes; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; herbal products, namely, herbal powders sold as an integral ingredient of nutritional supplements; dietary supplement drink mix for nutritional purposes; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for diabetics, infants and enteral feeding; botanical extracts as nutritional supplement for nutritional use; botanical extracts sold as components of nutraceuticals and pharmaceuticals; botanical extracts for medical, veterinary, nutraceutical and pharmaceutical purposes; designer extracts, namely, herbal extracts for medical, veterinary and pharmaceutical purposes; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as components of nutritional supplements and vitamins; nutritional oils for food and not for cosmetic purposes; food supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; food supplements, namely, anti-oxidants; food for medically restricted diets; dietary supplements, namely, vitamins and mineral supplements; anti-cough drops; cough drops; cough expectorants; throat lozenges; cough lozenges; cough syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention herpes; medical biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type ii or herpes zoster virus, not in intravenous form; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, hiv retinopathy, viral influenza "flu", herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus "herpes zoster" "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immunedeficiency virus "hiv", roseola infantum, human herpes iv; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes, herpes zoster and aids; functional foods, namely, dietetic foods adapted for medical purposes, food for diabetics, infants and enteral feeding, food for medically restricted diets; functional beverages, namely, nutritionally fortified beverages; medicinal foods, namely, processed food adapted for medical purposes; animal health products, namely, animal feed supplements, medicated animal feed, micro-nutrient animal feed, dietary supplements for animals, non-medicated additives for animal feed for use as nutritional supplements, nutritional drinks for animals, pharmaceutical preparations for animal skincare; plant extracts for medical, veterinary and pharmaceutical purposes; botanical extracts for medical, veterinary and pharmaceutical purposes; herbal extracts for medical, veterinary and pharmaceutical purposes; designer extracts, namely, plant, herbal and botanical extracts for medical, veterinary and pharmaceutical purposes; biodefense products, namely, medicinal preparations for the treatment of infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; nutritionally fortified beverages for immune enhancement; nutritionally fortified beverages with rice bran and wheat bran; algal products for medicinal purposes, namely, plant algal extracts and algal extract blends for use as nutritional and dietary supplements; algal products, namely, plant algal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; algal products, namely, plant algal powders for use as nutritional and dietary supplements; algal extracts and algal extract blends for medical or pharmaceutical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 6, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 6, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 2, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 7, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 7, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 18, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 2, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 22, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2012ALIEASSIGNED TO LIE—
Mar 27, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 5, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2011DOCKASSIGNED TO EXAMINER—
Jun 22, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 21, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance